Agilent Technologies, Human Metabolome Technologies Collaborate on Metabolomics Solution to Speed Disease and Drug Research; Agilent's Instrument Technology, HMT's Biochemical Expertise Combine to Help Scientists Map Human Metabolome.TOKYO -- Agilent Technologies This article needs sources or references that appear in reliable, third-party publications. Alone, primary sources and sources affiliated with the subject of this article are not sufficient for an accurate encyclopedia article. Inc. (NYSE NYSE See: New York Stock Exchange :A) and Human Metabolome Technologies, a Japanese bioventure, today announced they have signed an agreement to collaborate on an integrated set of metabolome analysis tools designed to help researchers discover potential therapeutics. Under the agreement, the two companies will work to integrate HMT's novel biochemical assays with Agilent's capillary electrophoresis Capillary electrophoresis (CE), also known as capillary zone electrophoresis (CZE), can be used to separate ionic species by their charge and frictional forces. In traditional electrophoresis, electrically charged analytes move in a conductive liquid medium under the (CE) and mass spectrometry mass spectrometry or mass spectroscopy Analytic technique by which chemical substances are identified by sorting gaseous ions by mass using electric and magnetic fields. (MS) technologies for the profiling, identification and quantitation of metabolic markers. Metabolomics, which aims to characterize the complete set of metabolites Metabolites Substances produced by metabolism or by a metabolic process. Mentioned in: Interactions , provides critical insights into how living things Living Things may refer to:
"The human metabolome is the next frontier of research beyond the genome and the proteome pro·te·ome n. The complete set of proteins that are produced by the genes of an organism. proteome the entire complement of proteins produced by a cell. , and metabolomics promises exciting advances," said Dr. Yoshihiro Ohtaki, president of HMT HMT Her Majesty's Treasury (UK) HMT Hazardous Materials Table (49 CFR 172.101) HMT Health Management Technology (magazine) HMT Higher Mother Tongue HMT Hindustan Machine Tools Ltd. . "The combination of Agilent's robust and sensitive CE/MS technology with our latest metabolomics methodologies will speed the identification of metabolites and improve scientists' ability to map the human metabolome." The Agilent and HMT metabolomics solution is expected to be on the market within six months. "Metabolomics is a rapidly emerging and promising area in life science research and an area of focus for Agilent," said Taia Ergueta, Agilent business manager for proteomics, Life Sciences and Chemical Analysis group. "We offer competencies in gene expression, separation technologies, mass spectrometry and informatics. The further application of HMT's expertise in metabolomics methodologies will speed the development of new tools for metabolomics research." Agilent and HMT are participating in the First International Conference of the Metabolomics Society in Tsuruoka City, Japan, today through June 23. About Human Metabolome Technologies Human Metabolome Technologies Inc. (HMT) was founded in July 2003 based on Capillary Electrophoresis-Mass Spectrometry (CE-MS) technologies that were developed by Masaru Tomita A Computer Science professor, specializing in natural language processing. Mr. Tomita is responsible for the inception of the GLR parser algorithm as well as much of its evolution. (Director of the Institute for Advanced Biosciences, Keio University Keio University (慶應義塾大学 Keiō gijuku daigaku ) and Tomoyoshi Soga (Associate Professor of Institute for Advanced Biosciences, Keio University). HMT technologies make it possible to measure over 1,600 metabolites in cells and organisms simultaneously and comprehensively, at high speed and with high resolution. HMT provides corporate partners with data of the metabolome measured by CE-MS and technical tools, which in turn help them develop products effectively, i.e., pharmaceuticals, functional foods and fermentation processes. HMT has already begun collaborations with several pharmaceutical and food companies for biomarker studies. Information about HMT is available on the Web at www.humanmetabolome.com. About Agilent Integrated Biology Solutions Agilent IBS IBS Irritable bowel syndrome, see there is a leading supplier of life science research systems that enable scientists to understand complex biological processes, determine disease mechanisms and speed drug discovery. Engineered for sensitivity, reproducibility and workflow productivity, Agilent's integrated biology solutions include instrumentation, microfluidics, software, microarrays, consumables and services for genomics, proteomics and metabolomics applications. About Agilent Technologies Agilent Technologies Inc. (NYSE:A) is the world's premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. The company's 28,000 employees serve customers in more than 110 countries. Agilent had net revenue of $7.2 billion in fiscal year 2004. Information about Agilent is available on the Web at www.agilent.com. Forward-Looking Statements This news release contains forward-looking statements as defined in the Securities Exchange Act of 1934 and is subject to the safe harbors created therein. The forward-looking statements contained herein include, but are not limited to, information regarding the timetable for making the Agilent/HMT metabolomics solution available to the market and the growth of the market for metabolomics solutions. Such information involves risks and uncertainties that could cause Agilent's results to differ materially from management's current expectations. Such risks and uncertainties include, but are not limited to the rapid development of life sciences technology and fluctuations in demand for life sciences products. In addition, other risks that Agilent faces in running its operations include the ability to execute successfully through business cycles while it continues to implement cost reductions; the ability to meet and achieve the benefits of its cost-reduction goals and otherwise successfully adapt its cost structures to continuing changes in business conditions; ongoing competitive, pricing and gross margin pressures; the risk that our cost-cutting initiatives will impair our ability to develop products and remain competitive and to operate effectively; the impact of geopolitical ge·o·pol·i·tics n. (used with a sing. verb) 1. The study of the relationship among politics and geography, demography, and economics, especially with respect to the foreign policy of a nation. 2. a. uncertainties on our markets and our ability to conduct business; the ability to improve asset performance to adapt to changes in demand; the ability to successfully introduce new products at the right time, price and mix and other risks detailed in Agilent's filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for the year ended Oct. 31, 2004, and our Quarterly Report on Form 10-Q Form 10-Q See 10-Q. for the period ended April 30, 2005. Forward-looking statements are based on the belief and assumptions of Agilent's management and on currently available information. Agilent undertakes no responsibility to publicly update or revise any forward-looking statement. NOTE TO EDITORS: Further technology, corporate citizenship Corporate Citizenship The extent to which businesses are socially responsible in meeting legal, ethical and economic responsibilities placed on them by shareholders. The aim it to create higher standards of living and quality of life in the community in which it operates, while and executive news is available on the Agilent news site at www.agilent.com/go/news. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion